WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1998002183) MEDICINAL COMPOSITIONS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1998/002183    International Application No.:    PCT/JP1997/002407
Publication Date: 22.01.1998 International Filing Date: 11.07.1997
Chapter 2 Demand Filed:    11.07.1997    
IPC:
A61K 31/4178 (2006.01), A61K 31/425 (2006.01), A61K 31/427 (2006.01), A61K 31/44 (2006.01), A61K 31/55 (2006.01), A61K 45/06 (2006.01)
Applicants: SANKYO COMPANY, LIMITED [JP/JP]; 5-1, Nihonbashi Honcho 3-chome, Chuo-ku, Tokyo 103 (JP) (For All Designated States Except US).
TSUJITA, Yoshio [JP/JP]; (JP) (For US Only).
FUJIWARA, Toshihiko [JP/JP]; (JP) (For US Only).
SADA, Toshio [JP/JP]; (JP) (For US Only).
MAEDA, Naoyuki [JP/JP]; (JP) (For US Only)
Inventors: TSUJITA, Yoshio; (JP).
FUJIWARA, Toshihiko; (JP).
SADA, Toshio; (JP).
MAEDA, Naoyuki; (JP)
Agent: NAKAMURA, Minoru; Shin-Tokyo Building, Room 646, 3-1, Marunouchi 3-chome, Chiyoda-ku, Tokyo 100 (JP)
Priority Data:
8/184368 15.07.1996 JP
Title (EN) MEDICINAL COMPOSITIONS
(FR) COMPOSITIONS MEDICINALES
Abstract: front page image
(EN)Medicinal compositions comprising as the active ingredient one or more drugs selected from the group consisting of angiotensin II receptor antagonists and angiotensin converting enzyme inhibitors and one or more drugs selected from the group consisting of insulin resistance improving agents. Because of showing excellent effects of inhibiting the progression of arteriosclerosis, these compositions are useful as drugs, in particular, preventives or remedies for arteriosclerosis.
(FR)Compositions médicinale comprenant comme ingrédient actif un ou plusieurs médicaments choisis dans le groupe comprenant les antagonistes du récepteur de l'angiotensine II et les inhibiteurs d'enzyme de conversion de l'angiotensine ainsi qu'un ou plusieurs médicaments choisis dans le groupe comprenant les agents d'amélioration de la résistance à l'insuline. En raison de leurs excellentes propriétés d'inhibition de la progression de l'artériosclérose, ces compositions sont utiles comme médicaments, en particulier comme médicaments préventifs ou de remèdes contre l'artériosclérose.
Designated States: AU, CA, CN, CZ, HU, IL, KR, MX, NO, NZ, RU, US.
European Patent Office (AT, BE, CH, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE).
Publication Language: Japanese (JA)
Filing Language: Japanese (JA)